Paul stoffels - Latest News Update, Information, Photos & Videos on Paul stoffels at Lokmat Times

Johnson & Johnson on Wednesday said that it has accelerated the first in-human clinical trial of its investigational SARS-CoV-2 vaccine in the second half of July via its Janssen Pharmaceutical Companies (Janssen).The trial for the vaccine, Ad26.COV2-S, recombinant, was initially scheduled to begin in September."Based on the strength of the preclinical data we have seen so far and interactions with the regulatory authorities, we have been able to further accelerate the clinical development of our investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant," said Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson."Simultaneously, we are continuing our efforts to build important global partnerships and invest in our vaccine production technology and manufacturing capabilities," he added in a statement.The randomised, double-blind, placebo-controlled Phase 1/2a study will evaluate the safety, reactogenicity (response to vaccination), and immunogenicity (immune response) of the vaccine in 1,045 healthy adults aged 18 to 55 years, as well as adults aged 65 years and older.The study will take place in the US and Belgium."Our goal is to ensure we can deliver a vaccine to the world and protect people everywhere from this pandemic," said the company.Over 100 vaccines are under various stages of trial and according to the scientists, it make take 12-18 months before a successful one is achieved.The company is in discussions with the National Institutes of Allergy and Infectious Diseases with the objective to start the Phase 3 vaccine clinical trial ahead of its original schedule, pending outcome of Phase 1 studies and approval of regulators.( With inputs from IANS )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

Paul StoffelsFOLLOW

Paul stoffels, Latest News

Health :J&J says Covid booster shot shot 94% effective

Washington, Sep 21 Johnson & Johnson on Tuesday announced that its booster shot, given two months after the ... ...

International :J&J's single-dose COVID-19 vaccine shows promising signs against Delta variant

Johnson & Johnson on Thursday (local time) announced that its single-shot COVID-19 vaccine showed promising signs of protection against the Delta variant rapidly spreading across the US and other countries, in a small laboratory study. ...

International :Johnson & Johnson trails shows vaccine effective even against variants

Johnson & Johnson's single-shot coronavirus vaccine protected against symptomatic and asymptomatic infection, and prevented hospitalization and death in all participants 28 days after vaccination, according to new clinical trial results published on ...

Health :'J&J vaccine 66% effective in preventing moderate to severe Covid'

Washington, Jan 30 American healthcare giant Johnson & Johnson's Covid-19 vaccine candidate is 66 per cent effective overall ... ...

Health :J&J reaches $1B Covid-19 vax deal with US

New York, Aug 6 Global healthcare company Johnson & Johnson has reached a $1 billion deal with the ... ...

Health :Johnson & Johnson to begin human trial of Covid vaccine in July

Johnson & Johnson on Wednesday said that it has accelerated the first in-human clinical trial of its investigational SARS-CoV-2 ... ...